Herpes Simplex Virus 2 News and Research

RSS
Herpes Simplex Virus-2 is a sexually transmitted viral infection, which often produces painful sores, usually in the genital area. Once infected, an individual may carry the virus and be subject to recurrent bouts of infection. Some estimate that as many as 20 percent of the adult population in the United States has been exposed to the virus.
FDA clears BioHelix IsoAmp HSV molecular diagnostic assay

FDA clears BioHelix IsoAmp HSV molecular diagnostic assay

USAID award supports study of SILCS diaphragm plus tenofovir gel on HIV, HSV

USAID award supports study of SILCS diaphragm plus tenofovir gel on HIV, HSV

Coridon demonstrates 100% protection using DNA HSV-2 vaccine

Coridon demonstrates 100% protection using DNA HSV-2 vaccine

Isconova expands Matrix M collaboration with Genocea to treat infectious diseases

Isconova expands Matrix M collaboration with Genocea to treat infectious diseases

DNA vaccine developer Coridon in U.S. collaboration

DNA vaccine developer Coridon in U.S. collaboration

New 3D herpes infection model brings hope

New 3D herpes infection model brings hope

Epstein-Barr virus might cause multiple sclerosis, study confirms

Epstein-Barr virus might cause multiple sclerosis, study confirms

Novel topically-applied molecular microbicide protects women against HIV infection

Novel topically-applied molecular microbicide protects women against HIV infection

Reprogrammed herpes virus can improve early cancer diagnosis

Reprogrammed herpes virus can improve early cancer diagnosis

African genital herpes strains are more infectious than the U.S. virus

African genital herpes strains are more infectious than the U.S. virus

Non-specific recurring genital symptoms could be undiagnosed herpes

Non-specific recurring genital symptoms could be undiagnosed herpes

Study suggests causal link between HSV1 and Alzheimer's disease

Study suggests causal link between HSV1 and Alzheimer's disease

Journal of Clinical Virology publishes positive outcome from CMX001 treatment against AdV infection

Journal of Clinical Virology publishes positive outcome from CMX001 treatment against AdV infection

Vical 2010 net loss increases to $30.4 million

Vical 2010 net loss increases to $30.4 million

Vical announces issuance of US patent for HSV-2 vaccine

Vical announces issuance of US patent for HSV-2 vaccine

Dermatologists urge athletes to be aware of most common skin infections

Dermatologists urge athletes to be aware of most common skin infections

Targeted delivery combination crosses brain protecting barrier and homes in on tumors

Targeted delivery combination crosses brain protecting barrier and homes in on tumors

IMDx enters multi-year agreement with Abbott Molecular for m2000 instrument system

IMDx enters multi-year agreement with Abbott Molecular for m2000 instrument system

Meganucleases used to prevent HSV-1 infection

Meganucleases used to prevent HSV-1 infection

Chimerix initiates enrollment in CMX001 clinical study for life-threatening conditions caused by dsDNA viruses

Chimerix initiates enrollment in CMX001 clinical study for life-threatening conditions caused by dsDNA viruses